Ceribell Infant Seizure Detection Software
Automatic Event Detection Software For Full-Montage Electroencephalograph. 510(k) K252070, from Ceribell, Inc. (Sunnyvale, CA). Product code OMB, class 2.
As of Nov 20, 2026, K252070 is an FDA 510(k) held by Ceribell, Inc., substantially equivalent on Nov 21, 2025 after 143 days, with no recalls tied to it in FDA's recall database.
- Review time: 143 days
- Recalls: 0
The Ceribell Infant Seizure Detection Software is intended to mark previously acquired sections of EEG recordings in newborns (defined as preterm or term neonates of 25-44 weeks postmenstrual age) and infants less than 1 year of age that may correspond to electrographic seizures in order to assist qualified clinical practitioners in the assessment of EEG traces.
- Ceribell Seizure Detection SoftwareK241589 · Ceribell, Inc. · Apr 9, 2025
- Ceribell Neurology Review SoftwareK260998 · Ceribell, Inc. · Jun 24, 2026
- Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15))K252160 · Persyst Development, LLC · Oct 31, 2025
- Ceribell Seizure Detection SoftwareK241589 · Ceribell, Inc. · Apr 9, 2025
- autoSCORE (V 2.0.0)K243743 · Holberg Eeg AS · Apr 9, 2025
- Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15))K242446 · Persyst Development Corporation · Jan 22, 2025
- NeuroMatchK241390 · LVIS Corporation · Nov 26, 2024
- REMI-AI Rapid Detection Module (REMI-AI RDM)K240408 · Epitel, Inc. · Oct 17, 2024
- encevis (2.1)K240993 · Ait Austrian Institute of Technology GmbH · Sep 27, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 1, 2025
- Review panel
- Neurology
- Regulation
- 21 CFR 882.1400
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files